Get the Stockscreener App
0.2912
6.76%
-0.0211
Glucotrack Inc stock is traded at $0.2912, with a volume of 272.30K.
It is down -6.76% in the last 24 hours and down -16.80% over the past month.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
See More
Previous Close:
$0.3123
Open:
$0.318
24h Volume:
272.30K
Relative Volume:
0.05
Market Cap:
$1.91M
Revenue:
-
Net Income/Loss:
$-16.89M
P/E Ratio:
-0.0139
EPS:
-20.8847
Net Cash Flow:
$-16.44M
1W Performance:
-40.81%
1M Performance:
-16.80%
6M Performance:
-91.96%
1Y Performance:
-96.20%
1-Day Range:
$0.291
$0.3449
1-Week Range:
$0.291
$0.46
52-Week Range:
$0.2907
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.2912 | 1.91M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Glucotrack Inc Stock (GCTK) Latest News
GCTK|GlucoTrack Inc|Price:0.325|Chg%:+0.012 - TradingKey
GCTK|GlucoTrack Inc|Price:0.313|Chg%:+0.007 - TradingKey
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack (GCTK) stock rallies 16% after hours: Here's what is going on - MSN
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Sahm
GlucoTrack Inc. (GCTK) Slips Slightly Amid Consolidation Near Key SupportVolume Spike Alerts - dars.gov.et
Press Release: Glucotrack, Inc. and Lōkahi Therapeutics(TM) Announce Strategic Financing Support From E.F. Hutton & Co. in Connection With Their Recently Completed Business Combination and Future Capital Markets Initiatives - Moomoo
Glucotrack completes bridge financing after merger By Investing.com - Investing.com South Africa
Glucotrack, Inc. (NASDAQ: GCTK) sets 2026 vote on reverse split and warrants - Stock Titan
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing - The Manila Times
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on - GlobeNewswire
Glucotrack Gains Slightly on Bridge Financing Deal - Baystreet.ca
Glucotrack Secures Bridge Financing Following Lōkahi Merger to Support Growth and Future Capital Raises - citybiz
Glucotrack completes bridge financing after merger - Investing.com
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives - The Manila Times
Lōkahi students assess shelved clinical assets for new opportunities - Stock Titan
GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On - Benzinga
Glucotrack completes business combination with Lōkahi Therapeutics - Investing.com
GlucoTrack and Lokahi Therapeutics: Paul Goode Will Serve as Chief Technical Officer of Combined Co and CEO of CBGM Subsidiary - Moomoo
GlucoTrack and Lokahi Therapeutics: Erik Emerson Appointed CEO of Combined Co - Moomoo
UPDATEGlucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - The Manila Times
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Glucotrack Completes Strategic Business Combination with Lōkahi Therapeutics to Form Publicly Listed Healthcare Platform - Quiver Quantitative
Glucotrack’s Glucose Monitor Will Operate as a Separate Subsidiary - Stock Titan
Glucotrack and Lōkahi Therapeutics Merge to Form Capital-Efficient Public Biopharma Platform Leveraging AI-Driven Asset Development 12 – Minichart - Minichart
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), upon the completion of the merger transaction between GlucoTrack, Inc. and Lokahi, the existing shareholders of Lokahi will receive shares equivalent to 19.99% of - Bitget
The board of Sprout Social, Inc. officially approved a personnel streamlining plan on July 8, 2026. - Bitget
Glucotrack (NASDAQ: GCTK) cedes 90% stake to Lokahi holders - Stock Titan
Glucotrack Merges With Lokahi Therapeutics; Former Holders to Own 90% Post-Conversion - TradingView
Glucotrack, Inc. (NASDAQ: GCTK) shifts control to Lokahi, adds $50M equity line - Stock Titan
Glucotrack Completes Lōkahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform - Yahoo Finance
Glucotrack Combines with Lōkahi Therapeutics - Medical Product Outsourcing
Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform - marketscreener.com
Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session - Benzinga
Glucotrack and Lōkahi Therapeutics Complete Strategic - GlobeNewswire
Glucotrack, Inc. and Lokahi Therapeutics Announces Executive Appointments to Its Combined Company - marketscreener.com
Glucotrack receives patent allowance for glucose monitoring system By Investing.com - Investing.com Nigeria
Lokahi Therapeutics Inc. entered into an Agreement and Plan of Merger to acquire GlucoTrack, Inc. in a reverse merger transaction. - marketscreener.com
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
Glucotrack expands IP to cover novel glucose monitor sensor architectures - Drug Delivery Business
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM - Yahoo Finance
Glucotrack Issued Notice of Allowance by USPTO for Patent Application Covering Implantable CBGM Platform - citybiz
Glucotrack receives patent allowance for glucose monitoring system - Investing.com
GlucoTrack Issued US Patent Office Allowance for Blood Glucose Monitoring System - marketscreener.com
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform - The Manila Times
Glucotrack Announces USPTO Notice Of Allowance For Patent Application Covering Its Implantable CBGM Platform - Menafn
Glucotrack patent wins USPTO notice as implantable glucose monitor advances - Stock Titan
GlucoTrack Inc. (GCTK) Holds Near Support Despite Modest DeclineLarge Cap Trends - DonanımHaber
GlucoTrack (GCTK) Stock Analysis Report | Financials & Insights - Benzinga
GlucoTrack Stock Declines 5% as Shares Test Key Support at $0.31Volume Breakout Ideas - dars.gov.et
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.37%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):